Logo image of CLDT

CHATHAM LODGING TRUST (CLDT) Stock Fundamental Analysis

NYSE:CLDT - New York Stock Exchange, Inc. - US16208T1025 - REIT

8.79  -0.04 (-0.45%)

After market: 8.73 -0.06 (-0.68%)

Fundamental Rating

2

CLDT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of CLDT have multiple concerns. CLDT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CLDT has reported negative net income.
In the past year CLDT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLDT reported negative net income in multiple years.
Of the past 5 years CLDT 4 years had a positive operating cash flow.
CLDT Yearly Net Income VS EBIT VS OCF VS FCFCLDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

CLDT has a worse Return On Assets (-0.86%) than 69.84% of its industry peers.
CLDT has a Return On Equity of -1.46%. This is in the lower half of the industry: CLDT underperforms 64.29% of its industry peers.
The Return On Invested Capital of CLDT (2.02%) is worse than 68.25% of its industry peers.
Industry RankSector Rank
ROA -0.86%
ROE -1.46%
ROIC 2.02%
ROA(3y)-0.61%
ROA(5y)-1.22%
ROE(3y)-1.09%
ROE(5y)-2.41%
ROIC(3y)N/A
ROIC(5y)N/A
CLDT Yearly ROA, ROE, ROICCLDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5 -10

1.3 Margins

CLDT has a worse Operating Margin (10.05%) than 81.75% of its industry peers.
CLDT's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 75.69%, CLDT is doing good in the industry, outperforming 73.02% of the companies in the same industry.
CLDT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.05%
PM (TTM) N/A
GM 75.69%
OM growth 3YN/A
OM growth 5Y-9.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y0.32%
CLDT Yearly Profit, Operating, Gross MarginsCLDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

CLDT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CLDT remains at a similar level compared to 1 year ago.
The number of shares outstanding for CLDT has been increased compared to 5 years ago.
The debt/assets ratio for CLDT is higher compared to a year ago.
CLDT Yearly Shares OutstandingCLDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CLDT Yearly Total Debt VS Total AssetsCLDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

CLDT has an Altman-Z score of 0.48. This is a bad value and indicates that CLDT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.48, CLDT is in line with its industry, outperforming 42.06% of the companies in the same industry.
CLDT has a Debt/Equity ratio of 0.57. This is a neutral value indicating CLDT is somewhat dependend on debt financing.
CLDT has a Debt to Equity ratio of 0.57. This is amongst the best in the industry. CLDT outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0.31
WACC6.55%
CLDT Yearly LT Debt VS Equity VS FCFCLDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

CLDT has a Current Ratio of 0.49. This is a bad value and indicates that CLDT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CLDT (0.49) is worse than 89.68% of its industry peers.
A Quick Ratio of 0.49 indicates that CLDT may have some problems paying its short term obligations.
With a Quick ratio value of 0.49, CLDT is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49
CLDT Yearly Current Assets VS Current LiabilitesCLDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

CLDT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -425.00%.
Looking at the last year, CLDT shows a small growth in Revenue. The Revenue has grown by 1.69% in the last year.
CLDT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.82% yearly.
EPS 1Y (TTM)-425%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y29.01%
Revenue growth 5Y-0.82%
Sales Q2Q%0.5%

3.2 Future

CLDT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -249.86% yearly.
CLDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.87% yearly.
EPS Next Y-1328%
EPS Next 2Y-249.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.43%
Revenue Next 2Y3.13%
Revenue Next 3Y2.87%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLDT Yearly Revenue VS EstimatesCLDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CLDT Yearly EPS VS EstimatesCLDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CLDT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CLDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLDT Price Earnings VS Forward Price EarningsCLDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

88.89% of the companies in the same industry are more expensive than CLDT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.28
CLDT Per share dataCLDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as CLDT's earnings are expected to decrease with -249.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-249.86%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

CLDT has a Yearly Dividend Yield of 3.19%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 18.51, CLDT is paying slightly less dividend.
CLDT's Dividend Yield is a higher than the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 3.19%

5.2 History

The dividend of CLDT decreases each year by -19.48%.
CLDT has paid a dividend for at least 10 years, which is a reliable track record.
CLDT has decreased its dividend recently.
Dividend Growth(5Y)-19.48%
Div Incr Years1
Div Non Decr Years1
CLDT Yearly Dividends per shareCLDT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of CLDT are negative and hence is the payout ratio. CLDT will probably not be able to sustain this dividend level.
CLDT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-199.96%
EPS Next 2Y-249.86%
EPS Next 3YN/A
CLDT Yearly Income VS Free CF VS DividendCLDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

More info and screens

CHATHAM LODGING TRUST

NYSE:CLDT (1/21/2025, 8:04:00 PM)

After market: 8.73 -0.06 (-0.68%)

8.79

-0.04 (-0.45%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners91.99%
Inst Owner Change0.05%
Ins Owners2.49%
Ins Owner Change4.71%
Market Cap429.92M
Analysts80
Price Target11.41 (29.81%)
Short Float %0.74%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield 3.19%
Yearly Dividend0.45
Dividend Growth(5Y)-19.48%
DP-199.96%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)63.4%
Min EPS beat(2)63.4%
Max EPS beat(2)63.4%
EPS beat(4)4
Avg EPS beat(4)38.81%
Min EPS beat(4)8.09%
Max EPS beat(4)63.4%
EPS beat(8)7
Avg EPS beat(8)30.12%
EPS beat(12)10
Avg EPS beat(12)153.6%
EPS beat(16)14
Avg EPS beat(16)126.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-1.11%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)0.24%
Revenue beat(8)3
Avg Revenue beat(8)-0.69%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)8
Avg Revenue beat(16)-0.79%
PT rev (1m)2.48%
PT rev (3m)4.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.69%
EPS NY rev (1m)0%
EPS NY rev (3m)6.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.37
P/FCF N/A
P/OCF 6.05
P/B 0.56
P/tB 0.56
EV/EBITDA 9.28
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.45
OCFY16.52%
SpS6.43
BVpS15.65
TBVpS15.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.86%
ROE -1.46%
ROCE 2.56%
ROIC 2.02%
ROICexc 2.05%
ROICexgc 2.05%
OM 10.05%
PM (TTM) N/A
GM 75.69%
FCFM N/A
ROA(3y)-0.61%
ROA(5y)-1.22%
ROE(3y)-1.09%
ROE(5y)-2.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-8.33%
ROICexc growth 3YN/A
ROICexc growth 5Y-8.33%
OM growth 3YN/A
OM growth 5Y-9.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y0.32%
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA 4.77
Cap/Depr 125.71%
Cap/Sales 23.94%
Interest Coverage 1.08
Cash Conversion 77.64%
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z 0.48
F-Score4
WACC6.55%
ROIC/WACC0.31
Cap/Depr(3y)109.04%
Cap/Depr(5y)101.41%
Cap/Sales(3y)25.78%
Cap/Sales(5y)24.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-425%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
EPS Next Y-1328%
EPS Next 2Y-249.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.69%
Revenue growth 3Y29.01%
Revenue growth 5Y-0.82%
Sales Q2Q%0.5%
Revenue Next Year2.43%
Revenue Next 2Y3.13%
Revenue Next 3Y2.87%
Revenue Next 5YN/A
EBIT growth 1Y-12.17%
EBIT growth 3YN/A
EBIT growth 5Y-10.72%
EBIT Next Year201.89%
EBIT Next 3Y50.29%
EBIT Next 5YN/A
FCF growth 1Y-173.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.62%
OCF growth 3YN/A
OCF growth 5Y-2.38%